The TJX Companies, Inc.
The TJX Companies, Inc. (TJX) Financial Performance & Income Statement Overview
Review The TJX Companies, Inc. (TJX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
The TJX Companies, Inc. (TJX) Income Statement & Financial Overview
Analyze The TJX Companies, Inc.’s TJX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $16.35B | $14.06B | $13.47B | $12.48B |
| Cost of Revenue | $11.37B | $9.62B | $9.38B | $8.74B |
| Gross Profit | $4.98B | $4.44B | $4.09B | $3.74B |
| Gross Profit Ratio | $0.30 | $0.32 | $0.30 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.13B | $2.75B | $2.67B | $2.40B |
| Operating Expenses | $3.13B | $2.75B | $2.67B | $2.40B |
| Total Costs & Expenses | $14.50B | $12.37B | $12.05B | $11.14B |
| Interest Income | $59.00M | $63.00M | $66.00M | $69.00M |
| Interest Expense | $17.00M | $20.00M | $20.00M | $19.00M |
| Depreciation & Amortization | $309.00M | $266.00M | $265.00M | $264.00M |
| EBITDA | $2.21B | $2.02B | $1.75B | $1.67B |
| EBITDA Ratio | $0.14 | $0.14 | $0.13 | $0.13 |
| Operating Income | $1.85B | $1.69B | $1.42B | $1.34B |
| Operating Income Ratio | $0.11 | $0.12 | $0.11 | $0.11 |
| Other Income/Expenses (Net) | $42.00M | $43.00M | $46.00M | $50.00M |
| Income Before Tax | $1.89B | $1.74B | $1.47B | $1.39B |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.11 | $0.11 |
| Income Tax Expense | $491.00M | $439.00M | $369.00M | $320.00M |
| Net Income | $1.40B | $1.30B | $1.10B | $1.07B |
| Net Income Ratio | $0.09 | $0.09 | $0.08 | $0.09 |
| EPS | $1.23 | $1.15 | $0.97 | $0.94 |
| Diluted EPS | $1.23 | $1.14 | $0.96 | $0.93 |
| Weighted Avg Shares Outstanding | $1.14B | $1.13B | $1.13B | $1.13B |
| Weighted Avg Shares Outstanding (Diluted) | $1.14B | $1.14B | $1.14B | $1.15B |
The company's financials show resilient growth, with revenue advancing from $12.48B in Q1 2025 to $16.35B in Q4 2025. Gross profit remained healthy with margins at 30% in Q4 2025 compared to 30% in Q1 2025. Operating income hit $1.85B last quarter, sustaining a consistent 11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.21B. Net income rose to $1.40B, while earnings per share reached $1.23. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan